FindTrial
Sign In

Application of thromboelastography (TEG) in the treatment of acute poisoning patients

Application of thromboelastography (TEG) in the treatment of acute poisoning patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029445
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute poisoning

Interventions

None listed

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with acute oral toxicosis (age 12 years and above); 2. patients and their families have good compliance; 3. All subjects or their guardians must sign the subject consent before entering the study; 4. Plan to enroll 100 eligible patients.

Exclusion criteria

Exclusion criteria: 1. patients and their families with poor compliance; 2. has been affected by the coagulation function of the disease.

Design outcomes

Primary

MeasureTime frame
thromboelastography;Four items of blood coagulation;—

Secondary

MeasureTime frame
Blood routine tests;Liver and renal function;—

Contacts

Public ContactJian Xiangdong

Qilu Hospital of Shandong University

jianxiangdongvip@163.com+86 18560083182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026